Orforglipron and Mitotane: Interaction Details
- Mitotane
- Lysodren
- Orforglipron
- Foundayo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Orforglipron and Mitotane interaction:
What Happens When You Take Orforglipron With Mitotane
What can happen when they are taken together (rated Major)
Reduced orforglipron exposure and reduced of orforglipron
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Orforglipron should not be used together with strong , because these agents can lower orforglipron exposure and, in turn, may diminish its effectiveness. In drug interaction studies, giving orforglipron with carBAMazepine (a strong CYP3A4 ) at 300 mg twice daily lowered orforglipron by 82% and by 55%.1
The Orforglipron and Mitotane Interaction, Explained
Mitotane can make orforglipron work less well. Mitotane speeds up a liver enzyme () that breaks down orforglipron, so your body may clear the medicine faster and you may end up with lower levels. That could mean weaker help with blood sugar or weight control.
In a study, another strong enzyme-speeding drug (carbamazepine) cut orforglipron levels by more than 80%. Mitotane's effect has not been measured the same way, but the same mechanism is expected. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and manage this safely.
Mechanism: Mitotane is a strong . Orforglipron is cleared by CYP3A4-mediated , so is expected to decrease exposure and (PK interaction, not a scenario).
- Magnitude: With carbamazepine 300 mg BID (strong CYP3A4 inducer), orforglipron fell 82% and 55%. Mitotane-specific data are not cited; the effect is inferred from the class.
- Onset: Unspecified. Mitotane induction is typically prolonged and may persist after discontinuation.
- Evidence: Probable.
- Management: Avoid . If unavoidable, monitor glycemic and weight response closely and have the prescriber individualize therapy or consider alternatives.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Orforglipron and Mitotane Interact
The likely mechanism
of -mediated of orforglipron
How to Manage the Orforglipron and Mitotane Interaction
The documented advice is to avoid using these two medicines together, because lower orforglipron levels may reduce how well it works.
- Keep taking both exactly as prescribed until your care team advises otherwise.
- Tell your pharmacist and prescriber that you take both, so they can decide whether orforglipron is still the right choice or an alternative fits better.
- If you stay on both, your team may monitor you more closely and individualize your treatment.
- Report any loss of benefit, such as rising blood sugar readings or reduced appetite control.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Orforglipron or Mitotane need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: FOUNDAYO oral tablet, orforglipron oral tablet
In drug interaction studies, of orforglipron with carBAMazepine (a strong ) at 300 mg twice daily lowered the of orforglipron by 82% and its by 55%.1
Orforglipron and Mitotane: Common Questions
How serious is the Orforglipron and Mitotane interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Orforglipron and Mitotane interaction managed?
The documented advice is to avoid using these two medicines together, because lower orforglipron levels may reduce how well it works. Keep taking both exactly as prescribed until your care team advises otherwise. Tell your pharmacist and prescriber that you take both, so they can decide whether orforglipron is still the right choice or an alternative fits better. If you stay on both, your team may… Management is individual — always follow your own care team's guidance.
Does taking Orforglipron and Mitotane at different times of day help?
No. Taking them at different times of day does not prevent this one. Mitotane speeds up , an enzyme that breaks down orforglipron, so orforglipron can be cleared faster. That change lasts while mitotane is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Orforglipron and Mitotane Interaction
Ask in your own words about taking Orforglipron and Mitotane together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: FOUNDAYO™ oral tablet, orforglipron oral tablet. Lilly USA LLC, Indianapolis, IN, 2026. DailyMed
Other Serious Interactions of Orforglipron and Mitotane
Also serious with Mitotane
- DoravirineContraindicated
- FostemsavirContraindicated
- Lenacapavir OralContraindicated
- LurasidoneContraindicated
Also serious with Orforglipron
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Mitotane
- Activated CharcoalMajor
- Slippery ElmModerate
- GlucomannanModerate
- Coffee CharcoalModerate
- European MandrakeModerate
- Guar GumModerate
- Gum ArabicModerate
- TragacanthModerate
- + 9 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.